Literature DB >> 16120716

Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.

Kenji Minoguchi1, Takuya Yokoe, Toshiyuki Tazaki, Hideko Minoguchi, Akihiko Tanaka, Naruhito Oda, Shinji Okada, Shin Ohta, Hirokuni Naito, Mitsuru Adachi.   

Abstract

Increased carotid intima-media thickness (IMT) and increased serum levels of inflammatory markers, such as C-reactive protein (CRP), interleukin (IL)-6, and IL-18, are associated with an increased risk of cardiovascular and cerebrovascular diseases. The aim of this study was to evaluate whether carotid IMT, a useful marker for early atherosclerosis, is associated with these inflammatory markers in patients with obstructive sleep apnea (OSA). Carotid IMT was investigated with ultrasonography in 36 patients with OSA and 16 obese control subjects. Serum levels of CRP, IL-6, and IL-18 were measured at 5:00 A.M. Carotid IMT (p < 0.001) and serum levels of CRP (p < 0.003), IL-6 (p < 0.005), and IL-18 (p < 0.03) of patients with OSA were significantly higher than those of obese control subjects. Carotid IMT was significantly correlated with serum levels of CRP (r = 0.61, p = 0.0001), IL-6 (r = 0.41, p = 0.01), and IL-18 (r = 0.45, p = 0.005), duration of OSA-related hypoxia (r = 0.60, p = 0.0001), and severity of OSA (r = 0.50, p = 0.002). In addition, the primary factor influencing carotid IMT was duration of hypoxia during total sleep time (p = 0.036). These results suggest that OSA-related hypoxia and systemic inflammation might be associated with the progression of atherosclerosis and thus might increase the risks of cardiovascular and cerebrovascular morbidity in patients with OSA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16120716     DOI: 10.1164/rccm.200412-1652OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  133 in total

1.  Stroke and sleep specialists: an opportunity to intervene?

Authors:  Nathaniel F Watson
Journal:  J Clin Sleep Med       Date:  2010-04-15       Impact factor: 4.062

Review 2.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

Review 3.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

4.  Mild obstructive sleep apnea syndrome should be treated. Pro.

Authors:  Lee K Brown
Journal:  J Clin Sleep Med       Date:  2007-04-15       Impact factor: 4.062

5.  [Sleep apnea and heart failure].

Authors:  T Plenge; J Müller-Ehmsen
Journal:  Herz       Date:  2013-09       Impact factor: 1.443

6.  Endothelial injury markers before and after nasal continuous positive airway pressure treatment for obstructive sleep apnoea hypopnoea syndrome.

Authors:  Maria Wilczynska; Samuel Rice; Gareth Davies; Keir E Lewis
Journal:  Sleep Breath       Date:  2013-12-11       Impact factor: 2.816

Review 7.  The role of interleukin 18 in the pathogenesis of hypertension-induced vascular disease.

Authors:  Simon W Rabkin
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2009-03

Review 8.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

9.  Time course of intermittent hypoxia-induced impairments in resistance artery structure and function.

Authors:  Nathan R Philippi; Cynthia E Bird; Noah J Marcus; E Burt Olson; Naomi C Chesler; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2009-12-05       Impact factor: 1.931

10.  Systemic inflammation in non-obese children with obstructive sleep apnea.

Authors:  David Gozal; Laura D Serpero; Oscar Sans Capdevila; Leila Kheirandish-Gozal
Journal:  Sleep Med       Date:  2007-09-06       Impact factor: 3.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.